Clinical Trials Browser

Phase 2 × sotigalimab × Gastrointestinal × Clear all

NCT04130854 2026-01-28

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Locally Advanced Rectal Adenocarcinoma

NCT03165994 2024-05-02

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

Phase 2 Completed

34 enrolled 18 charts

Gastrointestinal

Esophageal Neoplasms